Skip to main content
Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.17
-0.06 (-0.83%)
At close: Apr 28, 2026, 4:00 PM EDT
7.23
+0.06 (0.84%)
Pre-market: Apr 29, 2026, 8:47 AM EDT

Unicycive Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
22
Market Cap
180.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023675.00K-276.00K-29.02%
Dec 31, 2022951.00K--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 149.50M
Protalix BioTherapeutics 52.74M
Precision BioSciences 34.26M
Tonix Pharmaceuticals Holding 13.11M
Korro Bio 6.39M
Cartesian Therapeutics 2.80M
Humacyte 2.04M
Revenue Rankings

UNCY News

More News